X
No Ads. No Trackers. No Kidding! (Learn More)
Loading...
Thumbnail
Now that the U.S. is getting close to authorizing the first COVID-19 vaccine for younger teens, it will pave the way for immunizations to begin... [Read More]
Now that the U.S. is getting close to authorizing the first COVID-19 vaccine for younger teens, it will pave the way for immunizations to begin... [Read More]
Thumbnail
The Food and Drug Administration is expected to grant emergency authorization to Pfizer's COVID-19 vaccine for 12 to 15-year-olds within the week. If that... [Read More]
BioNTech SE BNTX, +8.94% ... [Read More]
Shares of ChemoCentryx Inc. undefined tumbled 61.7% in trading on Friday, the day after a Food and Drug Administration advisory committee voted 10-8 that the... [Read More]
Shares of ChemoCentryx Inc. CCXI, -61.59% ... [Read More]
A new analysis estimates that the number of people who died from COVID-19 globally, as well as in the U.S., is significantly higher than official... [Read More]
Shares of Epizyme Inc. undefined were up 11.0% in premarket trading on Friday after SVB Leerink upgraded the company's stock to outperform, from market... [Read More]
Thumbnail
It's been a complicated day for Moderna Inc. as the company reported its first-ever profit and its first-ever billion dollars in sales amidst an... [Read More]
It's been a complicated day for Moderna Inc. as the company reported its first-ever profit and its first-ever billion dollars in sales amidst an unprecedented... [Read More]
Moderna Inc. undefined said Thursday that initial data from the study evaluating its COVID-19 vaccine in teens between the ages of 12 and 17 years... [Read More]
Moderna Inc. MRNA, -6.19% ... [Read More]
Moderna Inc. undefined brought in $1.7 billion in sales of its COVID-19 vaccine in the first quarter of 2021, marking the company's first significant... [Read More]
Shares of Pfizer Inc. undefined gained 2.5% in trading on Wednesday after Canadian regulators said they authorized using the company's COVID-19 vaccine for... [Read More]
Shares of Pfizer Inc. PFE, +2.00% ... [Read More]
Pfizer Inc.'s COVID-19 vaccine is on track to generate a whopping $26 billion in sales this year, making it the drug maker's top-selling drug and... [Read More]
Pfizer Inc.'s COVID-19 vaccine is on track to generate a whopping $26 billion in sales this year, making it the drug maker's top-selling drug and... [Read More]
Of all the moving goal posts in the COVID-19 pandemic, herd immunity may be the most difficult to pin down — and it may even... [Read More]
Shares of ChemoCentryx Inc. undefined plunged 44.8% in trading on Tuesday after the Food and Drug Administration questioned the rationale behind some of the... [Read More]
Shares of Moderna Inc. MRNA, +4.03% ... [Read More]
Loading...
Save As
Preview
Preview